Gong, Ningqiang
Sheppard, Neil C.
Billingsley, Margaret M.
June, Carl H. http://orcid.org/0000-0003-0241-3557
Mitchell, Michael J. http://orcid.org/0000-0002-3628-2244
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2 TR002776, DP2 TR002776, DP2 TR002776, DP2 TR002776, DP2 TR002776)
Article History
Received: 4 May 2020
Accepted: 24 November 2020
First Online: 12 January 2021
Competing interests
: C.H.J. works under a research collaboration involving the University of Pennsylvania and the Novartis Institutes of Biomedical Research, Inc. C.H.J. is an inventor of intellectual property licensed by the University of Pennsylvania to Novartis. C.H.J. has sponsored research and equity from Tmunity Therapeutics. C.H.J. is a consultant for Immune Design, Viracta and Carisma. N.C.S. holds shares in Tmunity Therapeutics and Fate Therapeutics.